You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Rhinology
What treatments may be needed to achieve remission? And In what percentage of patients could remission be a target?
Prof. Hellings and Prof. Corso highlight that disease severity plays a key role in rate and control of remission in CRS.
MD, PhD
Peter Hellings
Learning objectives
- Understand the importance of considering patient heterogeneity in Chronic Rhinosinusitis (CRS) treatment, including the differentiation between mild, moderate, and severe cases, and the implications for achieving control and remission
- Recognize the significance of long-term observation and sustained control in evaluating the effectiveness of treatments, particularly the role of biologics in severe cases, and the necessity of continuous monitoring to confirm sustained remission
- Understand the role of type of the patients, severity of the disease, the endotype, and treatments that are evaluated in determining the percentage of patients to target for remission
Tags
MAT-GLB-2402936 - 1.0 - 07/2024
About this expert
Rhinology
Peter Hellings
MD, PhD
Professor and Clinic Head of the Department of Otorhinolaryngology | University Hospitals of Leuven, Belgium
See author’s profileRelated resources
